Literature DB >> 16399623

The roles of Akt and MAPK family members in silymarin's protection against UV-induced A375-S2 cell apoptosis.

Lin Hao Li1, Li Jun Wu, Shin Ichi Tashiro, Satoshi Onodera, Fumiaki Uchiumi, Takashi Ikejima.   

Abstract

Silymarin is a polyphenolic flavonoid derived from milk thistle (Silybum marianum) and has anti-inflammatory, cytoprotective as well as anticarcinogenic effects [Manna, S.K., Mukhopadlhyay, A., Van, N.T., Aggarwal, B., Silymarin suppresses TNF-induced activation of NF-kappaB, c-Jun N-terminal kinase, and apoptosis. J. Immunol. 1999; 163, 6800-6809.]. In this study, we assessed the effect of silymarin on ultraviolet light (UV)-induced cell apoptosis in human malignant melanoma, A375-S2 cells. Silymarin pre-treatment reversed the effect of UV irradiation on the expression of phosphorylated Akt and phosphorylated p53 (regulated by Akt activation), followed by down-regulation of Bax and up-regulated expressions of Bcl-2 and Bcl-xL proteins in UV-irradiated A375-S2 cells. Akt inhibitor decreased the viability of UV-irradiated cells which was treated with silymarin. In addition, the effect of UV irradiation on the phosphorylation of mitogen-activated protein kinase (MAPK) family members [extracellular signal-regulated kinase (ERK), p38 and c-Jun N-terminal kinase (JNK)] was also reversed by silymarin. Moreover, ERK inhibitor (PD98059) and p38 inhibitor (SB203580) augmented UV-induced apoptosis in silymarin treated A375-S2 cells. Consequently, silymarin partially reduced UV-induced apoptosis by activating the Akt pathway, and silymarin's protective effect was also exerted by MAPK family members.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16399623     DOI: 10.1016/j.intimp.2005.08.003

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

Review 1.  Botanicals for the prevention and treatment of cutaneous melanoma.

Authors:  Deeba N Syed; Hasan Mukhtar
Journal:  Pigment Cell Melanoma Res       Date:  2011-04-12       Impact factor: 4.693

Review 2.  Chemoprevention of melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Adv Pharmacol       Date:  2012

Review 3.  Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility.

Authors:  Monica Marzagalli; Marina Montagnani Marelli; Lavinia Casati; Fabrizio Fontana; Roberta Manuela Moretti; Patrizia Limonta
Journal:  Front Endocrinol (Lausanne)       Date:  2016-10-26       Impact factor: 5.555

4.  Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis.

Authors:  Sung-Hyun Kim; Gang-Sik Choo; Eun-Seon Yoo; Joong-Seok Woo; Jae-Han Lee; So-Hee Han; Soo-Hyun Jung; Hyeong-Jin Kim; Ji-Youn Jung
Journal:  Oncol Lett       Date:  2021-04-26       Impact factor: 2.967

5.  Silymarin Accelerates Liver Regeneration after Partial Hepatectomy.

Authors:  Jia-Ping Wu; Chin-Chuan Tsai; Yu-Lan Yeh; Yueh-Min Lin; Chien-Chung Lin; Cecilia Hsuan Day; Chia-Yao Shen; V Vijaya Padma; Lung-Fa Pan; Chih-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-03       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.